Overview
Grant Schofield is an Oncologist in Buffalo, New York. Dr. Schofield is rated as an Experienced provider by MediFind in the treatment of Thrombocytopenia. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Familial Colorectal Cancer, Muscle Invasive Bladder Cancer, and Bone Marrow Aspiration.
His clinical research consists of co-authoring 2 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Elm And Carlton St, Buffalo, NY 14263
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Niagara Falls Memorial Medical Center
Bhuvana Ramkumar is a Hematologist Oncology specialist and a Hematologist in Niagara Falls, New York. Dr. Ramkumar is rated as an Advanced provider by MediFind in the treatment of Thrombocytopenia. Her top areas of expertise are Thrombocytopenia, Monoclonal Gammopathy of Undetermined Significance (MGUS), Childhood Iron Deficiency Anemia, and Childhood Acute Myeloid Leukemia.
Rpci Oncology, PC
Jairus Ibabao is a Hematologist Oncology specialist and an Oncologist in Jamestown, New York. Dr. Ibabao is rated as a Distinguished provider by MediFind in the treatment of Thrombocytopenia. His top areas of expertise are Paget Disease of the Breast, Pleuropulmonary Blastoma, Chronic Lymphocytic Leukemia (CLL), and Lung Cancer.
Olean General Hospital
Hasan Rizvi is a Hematologist Oncology specialist and a Hematologist in Olean, New York. Dr. Rizvi is rated as an Advanced provider by MediFind in the treatment of Thrombocytopenia. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Paget Disease of the Breast, and Familial Colorectal Cancer.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Bladder CancerDr. Schofield isAdvanced. Learn about Bladder Cancer.
- Breast CancerDr. Schofield isAdvanced. Learn about Breast Cancer.
- Familial Colorectal CancerDr. Schofield isAdvanced. Learn about Familial Colorectal Cancer.
- Follicular LymphomaDr. Schofield isAdvanced. Learn about Follicular Lymphoma.
- Muscle Invasive Bladder CancerDr. Schofield isAdvanced. Learn about Muscle Invasive Bladder Cancer.
- Non-Muscle Invasive Bladder CancerDr. Schofield isAdvanced. Learn about Non-Muscle Invasive Bladder Cancer.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Schofield isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with MaturationDr. Schofield isExperienced. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Schofield isExperienced. Learn about Acute Myeloid Leukemia (AML).
- AgranulocytosisDr. Schofield isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Schofield isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.